Neuroendocrine Correlates of Temperament Traits in Abstinent Opiate Addicts

Journal of Substance Abuse

Volumn 11, Issue 4, 2000, Pages 337-354

  Gerra, Gilberto ^a,f   Zaimovic, Amir ^a   Timpano, Mariaemanuela ^a   Zambelli, Ursula ^a   Begarani, Marco ^a   Marzocchi, Gian Franco ^b   Ferri, Mila ^c   Delsignore, Roberto ^d   Brambilla, Francesca ^e  

^a Addiction Research Center of AUSL Parma   (Italy)

^b AUSL Modena   (Italy)

^c Substance Abuse Off Emilia R   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

^e IRCS S Raffaele   (Italy)

^f AUSL   (Italy)

Author keywords

Bromocriptine; Clonidine; Cortisol; D Fenfluramine; Dopamine; Growth hormone; Harm avoidance; Heroin addiction; Noradrenaline; Novelty seeking; Prolactin; Reward dependence; Serotonin

Indexed keywords

BROMOCRIPTINE; CLONIDINE; FENFLURAMINE; DOPAMINE; NORADRENALIN; SEROTONIN;

ADULT; ARTICLE; AVOIDANCE BEHAVIOR; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DETOXIFICATION; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL DISEASE; MONOAMINERGIC SYSTEM; NEUROENDOCRINOLOGY; NORADRENERGIC SYSTEM; OPIATE ADDICTION; PRIORITY JOURNAL; REWARD; SEROTONINERGIC SYSTEM; TEMPERAMENT; WITHDRAWAL SYNDROME; AROUSAL; CONTROL; HEROIN DEPENDENCE; MOTIVATION; PATHOPHYSIOLOGY; PERSONALITY TEST; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ADULT; AROUSAL; DOPAMINE; HEROIN DEPENDENCE; HUMANS; INTERNAL-EXTERNAL CONTROL; MALE; MOTIVATION; NOREPINEPHRINE; PERSONALITY INVENTORY; SEROTONIN; TEMPERAMENT;

EID: 0034566707     PISSN: 08993289     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-3289(00)00031-6     Document Type: Article

References (85)

1. Ampollini P., Marchesi C., Signifredi R., Maggini C. Temperament and personality features in panic disorder with or without comorbid mood disorders. Acta Psychiatr Scand. 95:1997;420-423.
2. Andrucci G.L., Archer R.P., Pancoast D.L., Gordon R.A. The relationship of MMPI and Sensation Seeking Scales to adolescent drug use. J Pers Assess. 53:1989;253-266.
3. Arque J.M., Beltri R., Torrubia R. Personality, bioelectric profile, and platelet monoamine oxidase activity in psychophysiological disorders: Headaches, insomnia, and loss of consciousness due to neurocirculatory dystonia. Psychiatry Psychobiol. 3:1988;263-267.
4. Asghari V., Schoots O., van Kats S., Ohara K., Jovanovic V., Guan H.C., Bunzow J.R., Petronis A., Van Tol H.H. Dopamine D4 receptor repeat: Analysis of different native and mutant forms of the human and rat genes. Mol Pharmacol. 46:1994;364-373.
5. Asghari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., Van Tol H.H. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem. 65(3):1995;1157-1165.
6. Auerbach J., Geller V., Lezer S., Shinwell E., Belmaker R.H., Levine J., Ebstein R. Dopamine D4 receptor (D4DR) and serotonin transporter promoter (5-HTTLPR) polymorphisms in the determination of temperament in 2-month-old infants. Mol Psychiatry. 4(4):1999;369-373.
7. Balldin J., Berggren U., Lindstedt G. A further neuroendocrine evidence for reduced D2 dopamine receptor function in alcoholism. Drug Alcohol Depend. 32:1993;159-162.
8. Ballenger J.C., Post R.M., Jimerson D.C. Biochemical correlates of personality traits in normals: An exploratory study. Pers Individ Differ. 4:1983;615-625.
9. Bardo M.T., Donohew R.L., Harrington N.G. Psychobiology of novelty seeking and drug seeking behavior. Behav Brain Res. 77:1996;23-43.
10. Benjamin J., Li L., Patterson C., Greenberg B.D., Murphy D.L., Hamer D.H. Population and familiar association between the D4 dopamine receptor gene and measures of novelty seeking. Nat Genet. 12:1996;81-84.
11. Berrettini W.H., Persico A.N. Dopamine D-2 receptor gene polymorphism and vulnerability to substance abuse in African Americans. Biol Psychiatr. 40:1996;144-147.
12. Brambilla F., Lampertico M., Panerai A.E., Sali L., Salerno F., Müller E.E. Effect of clonidine on the secretion of anterior pituitary hormones in heroin addicts and normal volunteers. Psychiatry Res. 13:1984;295-304.
13. Brambilla F., Carito M., Zanoboni A., Colla S.G., Müller E.E. Lisuride-induced stimulation of growth hormone releases and inhibition of prolactin secretion in heroin-addicted subjects and controls. Neuroendocrinol Lett. 10:1988;393-398.
14. Carrol E.N., Zuckerman M. Psychopathology and sensation seeking in "downers," "speeders" and "trippers": A study of the relationships between personality and drug choice. Int J Addict. 12:1977;591-601.
15. Cloninger C.R. A unfitted biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev. 3:1986;167-226.
16. Cloninger C.R. A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry. 44:1987;573-588.
17. Cloninger C.R. The psychobiological regulation of social cooperation. Nat Med. 1:1995;623-625.
18. Cloninger C.R. The genetics and psychobiology of the seven-factor model of personality. Silk K.R. Biology of Personality Disorders. 1998;63-91 American Psychiatric Press, Washington, DC.
19. Cloninger C.R., Sigvardsson S., Bohaman M. Childhood personality predicts alcohol abuse in young adult. Alchol Clin Exp Res. 12:1988;494-505.
20. Cloninger C.R., Svrakic D.M., Przybeck T.R. A psychobiological model of temperament and character. Arch Gen Psychiatry. 50:1993;975-990.
21. Cloninger C.R., Przybeck T.R., Svrakic D.M., Wetzel R.D. The Temperament and Character Inventory (TCI) A Guide to Its Development and Use. 1994;Washington University Center for the Psychobiology of Personality, St. Louis, MO.
22. Cloninger C.R., Adolfsson R., Svrakic N.M. Mapping genes for human personality. Nat Genet. 12:1996;3-4.
23. Comings R.G., Gade R., Wu S., Chiu C., Dietz G., Muhleman D., Saucier G., Ferry L., Rosenthal R.J., Lesieur H.R., Rugle L.J., MacMurray P. Studies of the potential role of the dopamine D-1 receptor gene in addictive behaviors. Mol Psychiatry. 2:1997;44-56.
24. Corr P.J., Pickering A.D., Gray J.A. Personality and reinforcement in associative and instrumental learning. Pers Individ Differ. 19:1995;47-71.
25. Dabbs J.M. Jr., Hopper C.H., Jurkovic G.J. Testosterone and personality among college students and military veterans. Pers Individ Differ. 11:1991;1263-1269.
26. Daitzman R.J., Zuckerman M. Disinhibitory sensation seeking, personality, and gonadal hormones. Pers Individ Differ. 1:1980;103-110.
27. Daitzman R.J., Zuckerman M., Sammelwitz P., Ganjam V. Sensation seeking and gonadal hormones. J Biosoc Sci. 10:1978;401-408.
28. Ebstein R.P., Levine J., Geller V., Auerbach J., Gritsenko I., Belmaker R.H. Dopamine D4 receptor and serotonin transporter promoter in the determination of neonatal temperament. Mol Psychiatry. 3:1998;238-246.
29. Ebstein R.P., Novick O., Umansky R. Dopamine D4 receptor (DRD4) exon III polymorphism associated with the human trait of novelty seeking. Nat Genet. 12:1996;78-80.
30. Fava M, Guaraldi GP, Mazzi F, Rigatelli M: Intervista Clinica Strutturata per il DSM-III-R, Florence, Organizzazioni Speciali, eds, 1993.
31. Fishbein D.H., Lozowsky D., Jaffe J.H. Impulsivity, aggression and neuroendocrine response to serotonergic stimulation in substance abuse. Biol Psychiatry. 25:1989;1049-1067.
32. Garcia Sevilla J.A., Ugedo L., Ulibarri I., Gutierrez M. Platelet alpha-2-adrenoceptors in heroin addicts during withdrawal and after treatment with clonidine. Eur J Pharmacol. 114:1985;365-374.
33. Garvey M.J., Noyes R. Jr., Cook B., Blum N. Preliminary confirmation of the proposed link between reward-dependence traits and norepinephrine. Psychiatry Res. 65:1996;61-64.
34. Gelernter J., Kranzler H., Coccaro E., Siever L., New A., Mulgrew C.L. D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects. Am J Hum Genet. 61:1997;1144-1152.
35. George MS, Kimbrell TA, Willis M, written communication, 1996.
36. Gerra G., Caccavari R., Fontanesi B., Fertonani-Affini G., Delsignore R., Brambilla F. Endocrinological effects of drugs and alcohol. Miller N.S., Gold M.S. Pharmacological Therapies for Drugs and Alcohol Addictions. 1994;53-75 Marcel Dekker, New York.
37. Gerra G., Caccavari R., Fontanesi B., Delsignore R., Fertonani A.G., Marcato A., Maestri D., Avanzini P., Perna G., Brambilla F. Alpha-2- adrenoreceptors sensitivity in heroin addicts with and without previous attention deficit disorder/hyperactivity and conduct disorder. Neuropsychobiology. 30:1994;15-19.
38. Gerra G., Caccavari R., Marcato A., Zaimovic A., Avanzini P., Monica C., Mutti A., Fontanesi B., Delsignore R., Brambilla F. Alpha-1 and 2-adrenoceptor subsensitivity in siblings of opioid addicts with personlaity disorders and depression. Acta Psychiatr Scand. 90:1994;269-273.
39. Gerra G., Tagliavini P., Zaimovic A., Fertonani G., Avanzini P., Caccavari R. Alpha-adrenergic and serotoninergic sensitivity in heroin addicts subtypes and their first degree relatives. Eight Sardinian Conf Neurosci. 6:1995;82. abstract.
40. Gerra G., Fertonani G., Tagliavini P., Zaimovic A., Delsignore R., Maestri D., Avanzini P., Caccavari R., Brambilla F. Serotonin function in detoxified heroin abusers: Prolactin and cortisol responses to fenfluramine challenge. Psychiatry Res. 58:1995;153-160.
41. Gerra G., Caccavari R., Zaimovic A., Palladino M., Chittolini B., Giucastro G., Maestri D., Monica C., Fertonani-Affini G., Delsignore R., Brambilla F. Serotoninergic function in mothers of opioid addicts: Correlation with comorbid depression. Acta Psychiatr Scand. 96:1997;36-42.
42. Gerra G., Ferri M., Zaimovic A., Giucastro G., Palladino M., Sartori R., Delsignore R., Maestri D., Marzocchi G., Brambilla F. Gabaergic function in detoxified heroin addicts: Relationship to anxiety. Psychiatry Res. 77:1998;89-96.
43. Gerra G., Avanzini P., Zaimovic A., Sartori R., Bocchi C., Timpano M., Zambelli U., Delsignore R., Gardini F., Talarico E., Brambilla F. Neurotransmitters, neuroendocrine correlates of novelty seeking temperament in normal humans. Neuropsychobiology. 39:1999;207-213.
44. Gerra G, Zaimovic A, Sartori R, Frati F, Bocchi C, Timpano M: Aggressiveness and novelty seeking temperament in subjects with a history of substance abuse, Psychoneuroendocrinology, in press.
45. Goldsmith H.H., Buss A.H., Polmin R., Rothbart M.K., Thomas A., Chess S., Hinde R.A., McCall R.B. Roundtable: What is temperament? Four approaches. Child Dev. 58:1987;505-529.
46. Guardia J., Catafau A.M., Batlle F., Martin J.C., Segura L., Gonzalvo B., Prat G., Carrio I., Casas M. Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients. Am J Psychiatry. 157:2000;127-129.
47. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
48. Hathaway S.R., McKinley J.C. Minnesota Multiphasic Personality Inventory-2. Manual. 1989;University of Minnesota, Minneapolis.
49. Heils A., Mossner R., Lesch K.P. The human serotonin transporter gene polymorphism - basic research and clinical implications. J Neural Transm. 104:1997;1005-1014.
50. Invernizzi R., Berettera C., Garattini S., Samanin R. D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur J Pharmacol. 120:1986;9-15.
51. Johansson F., Almay B.G.L., von Knorring L., Terrenius L.A. Personality traits in chronic patients related to endorphin levels in cerebrospinal fluid. Psychiatry Res. 1:1979;231-239.
52. Joyce P.R., Mulder R.T., Cloninger C.R. Temperament predicts clomipramine and desipramine response in major depression. J Affective Disord. 30:1994;35-46.
53. Kotler M., Cohen H., Segman R., Gritsenko I., Nemanov L., Lerer B., Kramer I., Zer-Zion M., Kletz I., Ebstein R.P. Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry. 2:1997;251-254.
54. LaHoste G.J., Swanson J.M., Wigal S.B., Glabe C., Wigal T., King N., Kennedy J.L. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry. 1:1996;121-124.
55. Leone P., Pocock D., Wise R.A. Morphine-dopamine interaction: Ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol Biochem Behav. 39:1991;469-472.
56. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 274:1996;1527-1531.
57. Lesch K.P., Jatzke S., Meyer J., Stober G., Okladnova O., Mossner R., Riederer P. Mosaicism for a serotonin transporter gene promoter-associated deletion: Decreased recombination in depression. J Neural Transm. 106:1999;1223-1230.
58. Mannuzza S., Klein R.G., Bessler A., Malloy P., LaPadula M. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry. 155:1998;493-498.
59. Manzanedo C., Aguilar M.A., Minarro J. The effects of dopamine D2 and D3 antagonists on spontaneous motor activity and morphine-induced hyperactivity in male mice. Psychopharmacology (Berlin). 143:1999;82-88.
60. Menza M.A., Mark M.H., Burn D.J., Brooks D.J. Personality correlates of 18F-dopa striatal uptake: Results of positron emission tomography in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 7:1995;176-179.
61. Moorman PP, deCocq van Delwijnen H, van Wessel K, Bauer H: Personality characteristics of drug addicts in the Netherlands, Leiden Psychological Reports LPR-PP02-89, the Netherlands, Department of Psychology, Leiden University, pp. 2-89, 1989.
62. Netter P., Henning J., Roed I.S. Serotonin and dopamine as mediators of sensation seeking behavior. Neuropsychobiology. 34:1996;155-165.
63. Nutt D.J. The neurochemistry of addiction. Hum Psychopharmacol. 12:1997;S53-S58.
64. Pfohl B., Blum N., Zimmerman M., Stangl D. Structured Interview for Personality Disorders, Revised Version. 1989;University of Iowa, Iowa City, IA.
65. Rasmussen K. The role of the locus coeruleus and N-methyl-D-aspartic Acid (NMDA) and AMPA receptors in opiate withdrawal. Neuropsychopharmacology. 13:1995;295-300.
66. Reitan R.M., Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. 1985;Neuropsychology Press, Tucson.
67. Rowe D.C., Stever C., Giedinghagen L.N., Gard J.M., Cleveland H.H., Terris S.T., Mohr J.H., Sherman S., Abramowitz A., Waldman I.D. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry. 3:1998;419-426.
68. Roy A., Adinoff B., Linnoila M. Acting out hostility in normal volunteers: Negative correlation with levels of 5-HIAA in cerebrospinal fluid. Psychiatry Res. 24:1988;187-194.
69. Ruegg R.G., Gilmore J., Ekstrom R.D., Corrigan M., Knight B., Tancer M., Leatherman M.E., Carson S.W., Golden R.N. Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects. Biol Psychiatry. 42:1997;1123-1129.
70. Schmidt L.G., Dufen P., Heinz A., Kuhu S., Rommelspalter H. Serotoninergic dysfunction in addiction: Effects of alcohol, cigarette smoking and heroin on platelet 5-HT content. Psychiatry Res. 72:1997;177-186.
71. Self D.W., McClenahan A., Beitner-Johnson D., Terwilliger R.Z., Nestler E.J. Biochemical adaptations in the mesolimbic dopamine system in response to heroin self-administration. Synapse. 21:1995;312-318.
72. Siever L.J., Davis K.L. A psychobiologic perspective on the personality disorders. Am J Psychiatry. 148:1991;1646-1658.
73. Skolnick N.J., Zuckerman M. Personality changes in drug abusers: A comparison of therapeutic community and prison group. J Consult Clin Psychol. 47:1979;768-770.
74. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. Structured Clinical Interview according to DSM-III-R. 1990;American Psychiatric Press, Washington, DC.
75. Storlien L.H., Smythe G.A. D-Fenfluramine effects on hypothalamic monoamine activities and their hormonal correlates. Brain Res. 597:1992;60-65.
76. Teichman M., Barnea Z., Rahav G. Sensation seeking, state and trait anxiety, and depressive mood in adolescent substance users. Int J Addict. 24:1989;87-89.
77. Vandenbergh D.J., Rodriguez L.A., Miller I.T., Uhl G.R., Lachman H.M. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet. 74:1997;439-442.
78. Volkow N.D., Ding Y.S., Fowler J.G., Wang G.J. Cocaine addiction: Hypothesis derived from imaging studies with PET. J Addict Dis. 15:1996;55-71.
79. Vukov M., Baba-Milkic N., Lecic D., Mijalkovic S., Marinkovic J. Personality dimensions of opiate addicts. Acta Psychiatr Scand. 91:1995;103-107.
80. Wang G.J., Volkow N.D., Fowler J.S., Logan J., Abumrad N.N., Hitzemann R.J., Pappas N.S., Paskani K. Dopamine D-2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology. 16:1997;174-182.
81. Wechsler C.D. Manual for the Wechsler Adult Intelligence Scale. 1955;The Psychological Corporation, San Antonio, TX.
82. Wechsler C.D. WAIS-R Manual. 1985;The Psychological Corporation, San Antonio, TX.
83. Zuckerman M. The psychophysiology of sensation seeking. J Pers. 58:1990;313-345.
84. Zuckerman M. Zuckerman M. Behavioral Expressions and Biosocial Bases of Sensation Seeking. 1994;Cambridge Univ. Press, Melbourne, Australia.
85. Zuckerman M. The psychobiological model for impulsive unsocialized sensation seeking a comparative approach. Neuropsychobiology. 14:1996;125-129.